{"id":112615,"date":"2021-06-15T10:00:25","date_gmt":"2021-06-15T10:00:25","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=112615"},"modified":"2021-06-15T10:00:25","modified_gmt":"2021-06-15T10:00:25","slug":"marshfield-clinic-case","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/","title":{"rendered":"Marshfield clinic case"},"content":{"rendered":"<p>A federal antitrust case in which the appellate opinion suggests that providers can freely deal with (or even refuse to deal with) insurance companies even where the providers have a &#8220;natural monopoly&#8221; (the market is just too small to support additional providers). At trial it was argued that a provider (Marshfield Clinic and its wholly-owned HMO) had violated federal antitrust laws by signing up virtually all of the physicians within its market area into its managed care program with exclusive contracts, thereby preventing an insurance company (Blue Cross &amp; Blue Shield of Wisconsin and its HMO) from competing on a &#8220;level playing field.&#8221; The jury in the original federal district court case agreed with Blue Cross and awarded them $48 million, after trial reduced to around $20 million. Virtually every issue at trial, however, was reversed in September 1995 by the Court of Appeals for the Seventh Circuit. Central to the appellate courts opinion was the conclusion that HMOs were not a separate or unique health care market in the area, but simply another way of pricing medical care, much like PPOs or other forms of managed care.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A federal antitrust case in which the appellate opinion suggests that providers can freely deal with (or even refuse to deal with) insurance companies even where the providers have a &#8220;natural monopoly&#8221; (the market is just too small to support additional providers). At trial it was argued that a provider (Marshfield Clinic and its wholly-owned [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-112615","post","type-post","status-publish","format-standard","hentry","category-m"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Marshfield clinic case - Definition of Marshfield clinic case<\/title>\n<meta name=\"description\" content=\"A federal antitrust case in which the appellate opinion suggests that providers can freely deal with (or even refuse to deal with) insurance companies even where the providers have a &quot;natural monopoly&quot; (the market is just too small to support additional providers). At trial it was argued that a provider (Marshfield Clinic and its wholly-owned HMO) had violated federal antitrust laws by signing up virtually all of the physicians within its market area into its managed care program with exclusive contracts, thereby preventing an insurance company (Blue Cross &amp; Blue Shield of Wisconsin and its HMO) from competing on a &quot;level playing field.&quot; The jury in the original federal district court case agreed with Blue Cross and awarded them $48 million, after trial reduced to around $20 million. Virtually every issue at trial, however, was reversed in September 1995 by the Court of Appeals for the Seventh Circuit. Central to the appellate courts opinion was the conclusion that HMOs were not a separate or unique health care market in the area, but simply another way of pricing medical care, much like PPOs or other forms of managed care.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marshfield clinic case - Definition of Marshfield clinic case\" \/>\n<meta property=\"og:description\" content=\"A federal antitrust case in which the appellate opinion suggests that providers can freely deal with (or even refuse to deal with) insurance companies even where the providers have a &quot;natural monopoly&quot; (the market is just too small to support additional providers). At trial it was argued that a provider (Marshfield Clinic and its wholly-owned HMO) had violated federal antitrust laws by signing up virtually all of the physicians within its market area into its managed care program with exclusive contracts, thereby preventing an insurance company (Blue Cross &amp; Blue Shield of Wisconsin and its HMO) from competing on a &quot;level playing field.&quot; The jury in the original federal district court case agreed with Blue Cross and awarded them $48 million, after trial reduced to around $20 million. Virtually every issue at trial, however, was reversed in September 1995 by the Court of Appeals for the Seventh Circuit. Central to the appellate courts opinion was the conclusion that HMOs were not a separate or unique health care market in the area, but simply another way of pricing medical care, much like PPOs or other forms of managed care.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-15T10:00:25+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/\",\"name\":\"Marshfield clinic case - Definition of Marshfield clinic case\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-06-15T10:00:25+00:00\",\"dateModified\":\"2021-06-15T10:00:25+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A federal antitrust case in which the appellate opinion suggests that providers can freely deal with (or even refuse to deal with) insurance companies even where the providers have a \\\"natural monopoly\\\" (the market is just too small to support additional providers). At trial it was argued that a provider (Marshfield Clinic and its wholly-owned HMO) had violated federal antitrust laws by signing up virtually all of the physicians within its market area into its managed care program with exclusive contracts, thereby preventing an insurance company (Blue Cross & Blue Shield of Wisconsin and its HMO) from competing on a \\\"level playing field.\\\" The jury in the original federal district court case agreed with Blue Cross and awarded them $48 million, after trial reduced to around $20 million. Virtually every issue at trial, however, was reversed in September 1995 by the Court of Appeals for the Seventh Circuit. Central to the appellate courts opinion was the conclusion that HMOs were not a separate or unique health care market in the area, but simply another way of pricing medical care, much like PPOs or other forms of managed care.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marshfield clinic case\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marshfield clinic case - Definition of Marshfield clinic case","description":"A federal antitrust case in which the appellate opinion suggests that providers can freely deal with (or even refuse to deal with) insurance companies even where the providers have a \"natural monopoly\" (the market is just too small to support additional providers). At trial it was argued that a provider (Marshfield Clinic and its wholly-owned HMO) had violated federal antitrust laws by signing up virtually all of the physicians within its market area into its managed care program with exclusive contracts, thereby preventing an insurance company (Blue Cross & Blue Shield of Wisconsin and its HMO) from competing on a \"level playing field.\" The jury in the original federal district court case agreed with Blue Cross and awarded them $48 million, after trial reduced to around $20 million. Virtually every issue at trial, however, was reversed in September 1995 by the Court of Appeals for the Seventh Circuit. Central to the appellate courts opinion was the conclusion that HMOs were not a separate or unique health care market in the area, but simply another way of pricing medical care, much like PPOs or other forms of managed care.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/","og_locale":"en_US","og_type":"article","og_title":"Marshfield clinic case - Definition of Marshfield clinic case","og_description":"A federal antitrust case in which the appellate opinion suggests that providers can freely deal with (or even refuse to deal with) insurance companies even where the providers have a \"natural monopoly\" (the market is just too small to support additional providers). At trial it was argued that a provider (Marshfield Clinic and its wholly-owned HMO) had violated federal antitrust laws by signing up virtually all of the physicians within its market area into its managed care program with exclusive contracts, thereby preventing an insurance company (Blue Cross & Blue Shield of Wisconsin and its HMO) from competing on a \"level playing field.\" The jury in the original federal district court case agreed with Blue Cross and awarded them $48 million, after trial reduced to around $20 million. Virtually every issue at trial, however, was reversed in September 1995 by the Court of Appeals for the Seventh Circuit. Central to the appellate courts opinion was the conclusion that HMOs were not a separate or unique health care market in the area, but simply another way of pricing medical care, much like PPOs or other forms of managed care.\u00a0","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/","og_site_name":"Glossary","article_published_time":"2021-06-15T10:00:25+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/","name":"Marshfield clinic case - Definition of Marshfield clinic case","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-06-15T10:00:25+00:00","dateModified":"2021-06-15T10:00:25+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A federal antitrust case in which the appellate opinion suggests that providers can freely deal with (or even refuse to deal with) insurance companies even where the providers have a \"natural monopoly\" (the market is just too small to support additional providers). At trial it was argued that a provider (Marshfield Clinic and its wholly-owned HMO) had violated federal antitrust laws by signing up virtually all of the physicians within its market area into its managed care program with exclusive contracts, thereby preventing an insurance company (Blue Cross & Blue Shield of Wisconsin and its HMO) from competing on a \"level playing field.\" The jury in the original federal district court case agreed with Blue Cross and awarded them $48 million, after trial reduced to around $20 million. Virtually every issue at trial, however, was reversed in September 1995 by the Court of Appeals for the Seventh Circuit. Central to the appellate courts opinion was the conclusion that HMOs were not a separate or unique health care market in the area, but simply another way of pricing medical care, much like PPOs or other forms of managed care.\u00a0","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/marshfield-clinic-case\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Marshfield clinic case"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/112615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=112615"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/112615\/revisions"}],"predecessor-version":[{"id":112616,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/112615\/revisions\/112616"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=112615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=112615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=112615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}